Evidence map›Paper›PMID 41802198›Full record

ArticleGigaScience2026

Multiplatform comparisons and annotation of structural variants highlight the utility of the T2T reference genome in human diagnostics.

Jakub Savara, Tomas Novosad, Petr Gajdos, Anna Petrackova, Marek Behalek, Jirina Manakova, Filip Ctvrtlik, Jiri Minarik, Tomas Papajik, Eva Kriegova

Abstract readComparative Study
In one paragraph

Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jakub SavaraDepartment of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Hnevotinska 3, 77900 Olomouc, Czech Republic.ORCID 0000-0003-3067-7867
Tomas NovosadDepartment of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 17. listopadu 2172/15, 70800 Ostrava, Czech Republic.ORCID 0000-0003-2291-261X
Petr GajdosDepartment of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 17. listopadu 2172/15, 70800 Ostrava, Czech Republic.ORCID 0000-0003-1831-3489
Anna PetrackovaDepartment of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Hnevotinska 3, 77900 Olomouc, Czech Republic.ORCID 0000-0001-5210-4504
Marek BehalekDepartment of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 17. listopadu 2172/15, 70800 Ostrava, Czech Republic.ORCID 0000-0002-9204-2691
Jirina ManakovaDepartment of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Hnevotinska 3, 77900 Olomouc, Czech Republic.ORCID 0000-0001-6931-5666
Filip CtvrtlikDepartment of Radiology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic.ORCID 0000-0003-1490-7175
Jiri MinarikDepartment of Hemato-oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic.ORCID 0000-0003-0513-326X
Tomas PapajikDepartment of Hemato-oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic.ORCID 0000-0001-5779-1139
Eva KriegovaDepartment of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Hnevotinska 3, 77900 Olomouc, Czech Republic.ORCID 0000-0002-8969-4197

Funding

Ministry of Health of the Czech Republic 00098892Ministry of Health of the Czech Republic MH CZ-DROMinistry of Health of the Czech Republic NW24-10-00395Palacký University JG_2025_035
6 · The paper itself

Abstract

backgroundStructural variants (SVs) are increasingly recognized as key contributors to human diseases. However, our understanding of SVs in health and disease is limited, mainly due to their structural complexity and variable length in individuals, as well as limitations inherent to the available genomic technologies and reference genome used.

resultsTo systematically evaluate SVs across human whole-genome samples using hg38/GRCh38 and gapless T2T-CHM13 references, we introduced an innovative multiplatform approach, LongReadChecker (LoReC), which advances SV comparison and annotation based on distance variance, intersection, gene overlap, and the closest SV in the clinical database. Comparison of the performance in detecting SVs from public and our own whole-genome datasets from short-read sequencing (SRS), available long-read sequencing (LRS) platforms, and optical genome mapping (OGM) revealed that most SVs detected by SRS were confirmed by LRS, but LRS can identify twice as many SVs (25,000 SVs/genome) with greater read mapping accuracy. Our LongReadChecker (LoReC) analysis further highlights the utility of the T2T-CHM13 reference in SV detection, as 20% more deletions and 20% less insertions were detected compared with hg38/GRCh38, which was particularly evident in long-read datasets. Since 80% of the SVs detected by LRS/SRS are smaller than 0.5 kbp, OGM did not detect them.

conclusionsOur study revealed that introducing distance variance, intersection, gene overlap, and the closest SV in the clinical database may help compare and annotate SVs in diagnostics. Our data showed that LRS, together with T2T-CHM13 gapless sequences, can improve the diagnostics of patients with human diseases when SRS fails to identify the cause.

Indexed as

Genome, HumanGenomicsGenomic Structural VariationComputational BiologyHigh-Throughput Nucleotide SequencingHumansMolecular Sequence AnnotationSequence Analysis, DNASoftwareannotationsLongReadChecker (LoReC) toolkitlong-read technologynext-generation sequencingstructural variants

Identifiers

PMID41802198
PMCPMC13137335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.